Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00679549 · ClinicalTrials.gov registry record · NA
The Role of Sleep Apnea in the Acute Exacerbation of Heart Failure
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
NCT00679549 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 154 participants.
The verdict
NCT00679549, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
Study Summary
This study will evaluate whether treating sleep apnea while in the hospital would help heart failure, and assist recovery from the worsening of the heart function more than the current clinical standard of waiting for treatment until the subject have left the hospital. Heart failure affects more than 2% of the US population and is the only cardiovascular disorder with rising incidence. The annual cost of CHF in 2005 was $ 27.9 billion, large percentage of which is the cost of hospitalizations for exacerbation of CHF. Half of patients with CHF have some form of sleep apnea, and most of them go undiagnosed. Patients with CHF and OSA benefit from treatment with CPAP as an outpatient. The society can benefit from developing recommendations for approaching sleep apnea in the hospitalized CHF patient, which may shorten length of stay, improve functional status of discharged patient, and reduce rehospitalizations.
Interventions
- DEVICE CPAP Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2008-03 |
| Est. Completion | 2014-03-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00679549
The ClinicalTrials.gov registry entry for NCT00679549 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CPAP Therapy is the first listed.
NCT00679549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00679549 about?
NCT00679549 is a clinical study titled "The Role of Sleep Apnea in the Acute Exacerbation of Heart Failure". This study will evaluate whether treating sleep apnea while in the hospital would help heart failure, and assist recovery from the worsening of the heart function more than the current clinical standard of waiting for treatment until the subject have left the hospital. Heart failure affects more th...
What is the current status of trial NCT00679549?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2008-03. Estimated completion is 2014-03-22.
What interventions are being tested in trial NCT00679549?
The interventions under investigation include: CPAP Therapy (DEVICE).
Who is sponsoring clinical trial NCT00679549?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.